Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,600,886
+$168,141 QoQ
Shares Held
26,513
-1.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#561
of 3,140 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laird Norton Wetherby Trust Company, LLC holds $154,805,158 across 14 Drug Manufacturers - General names. AMGN ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
38,934 | $46,698,611 | |
| 2 | JNJ |
Johnson & Johnson
|
100,512 | $25,527,031 | |
| 3 | ABBV |
AbbVie Inc.
|
71,949 | $18,105,246 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,602 | $13,184,357 | |
| 5 | NVS |
Novartis AG
|
67,193 | $10,530,486 | |
| 6 | AMGN |
Amgen Inc
This page
|
26,513 | $9,600,886 | |
| 7 | AZN |
Astrazeneca PLC
|
49,857 | $9,453,883 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
44,230 | $5,588,017 |
All Filings in AMGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,600,886 | 26,513 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $9,432,745 | 26,809 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $8,921,815 | 27,258 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||